Free Trial

AirSculpt Technologies, Inc. (NASDAQ:AIRS) CEO Dennis Dean Sells 7,719 Shares

AirSculpt Technologies logo with Business Services background

AirSculpt Technologies, Inc. (NASDAQ:AIRS - Get Free Report) CEO Dennis Dean sold 7,719 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $7.53, for a total transaction of $58,124.07. Following the completion of the transaction, the chief executive officer now owns 628,940 shares in the company, valued at $4,735,918.20. This trade represents a 1.21 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Dennis Dean also recently made the following trade(s):

  • On Friday, November 15th, Dennis Dean sold 24,510 shares of AirSculpt Technologies stock. The stock was sold at an average price of $6.54, for a total transaction of $160,295.40.

AirSculpt Technologies Stock Performance

AirSculpt Technologies stock traded down $0.45 during midday trading on Friday, hitting $6.51. The stock had a trading volume of 354,838 shares, compared to its average volume of 85,377. The firm's fifty day moving average is $5.55 and its two-hundred day moving average is $4.75. The company has a market capitalization of $376.80 million, a PE ratio of -46.50 and a beta of 1.57. AirSculpt Technologies, Inc. has a 52-week low of $2.92 and a 52-week high of $9.20. The company has a current ratio of 0.51, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80.

AirSculpt Technologies (NASDAQ:AIRS - Get Free Report) last released its earnings results on Friday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The firm had revenue of $42.55 million during the quarter, compared to analysts' expectations of $42.49 million. AirSculpt Technologies had a positive return on equity of 2.22% and a negative net margin of 4.13%. During the same period in the prior year, the company posted ($0.01) earnings per share. On average, research analysts forecast that AirSculpt Technologies, Inc. will post 0.15 EPS for the current year.

Institutional Investors Weigh In On AirSculpt Technologies

A number of institutional investors have recently added to or reduced their stakes in the stock. SW Investment Management LLC grew its holdings in AirSculpt Technologies by 5.0% during the 2nd quarter. SW Investment Management LLC now owns 4,500,000 shares of the company's stock valued at $18,000,000 after buying an additional 213,677 shares in the last quarter. Vanguard Group Inc. grew its holdings in AirSculpt Technologies by 1.0% during the 1st quarter. Vanguard Group Inc. now owns 576,038 shares of the company's stock valued at $3,537,000 after buying an additional 5,606 shares in the last quarter. FourWorld Capital Management LLC purchased a new stake in AirSculpt Technologies during the 1st quarter valued at approximately $557,000. Finally, Barclays PLC grew its holdings in AirSculpt Technologies by 227.0% during the 3rd quarter. Barclays PLC now owns 19,100 shares of the company's stock valued at $97,000 after buying an additional 13,259 shares in the last quarter. 91.54% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, BTIG Research started coverage on shares of AirSculpt Technologies in a research note on Thursday, October 17th. They issued a "neutral" rating on the stock. Five research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $5.50.

View Our Latest Research Report on AirSculpt Technologies

About AirSculpt Technologies

(Get Free Report)

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in AirSculpt Technologies right now?

Before you consider AirSculpt Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AirSculpt Technologies wasn't on the list.

While AirSculpt Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines